1. Home
  2. FCF vs IMCR Comparison

FCF vs IMCR Comparison

Compare FCF & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Commonwealth Financial Corporation

FCF

First Commonwealth Financial Corporation

HOLD

Current Price

$17.32

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$33.30

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCF
IMCR
Founded
1934
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FCF
IMCR
Price
$17.32
$33.30
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$19.50
$64.30
AVG Volume (30 Days)
669.5K
350.2K
Earning Date
01-27-2026
02-25-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
N/A
EPS
1.39
N/A
Revenue
$468,728,000.00
$379,590,000.00
Revenue This Year
$17.35
$32.42
Revenue Next Year
$7.59
$11.17
P/E Ratio
$12.57
N/A
Revenue Growth
2.69
28.11
52 Week Low
$13.54
$23.15
52 Week High
$18.28
$40.72

Technical Indicators

Market Signals
Indicator
FCF
IMCR
Relative Strength Index (RSI) 55.62 42.18
Support Level $16.97 $32.00
Resistance Level $17.73 $34.71
Average True Range (ATR) 0.35 1.49
MACD 0.00 -0.01
Stochastic Oscillator 67.17 34.83

Price Performance

Historical Comparison
FCF
IMCR

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: